AKT1 and neoplasm: The anti-cancer and anti-metastasis effects of matrine inhibit EMT induced by M2-like macrophages via the AKT/PI3K signaling pathways, boosting T-cell-mediated anti-tumor immunity by targeting TAMs (132).